STOCK TITAN

IGM Biosciences to Present at the 40th Annual J.P. Morgan Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

IGM Biosciences, a clinical-stage biotechnology company, announced that CEO Fred Schwarzer will present virtually at the 40th Annual J.P. Morgan Healthcare Conference on January 12, 2022, at 10:30 a.m. EST. The presentation will be accessible via a live webcast on the Company’s website, with a replay available for 30 days afterward. IGM Biosciences focuses on developing engineered IgM antibodies, addressing manufacturing and engineering challenges to enhance therapeutic applications compared to IgG antibodies.

Positive
  • None.
Negative
  • None.

MOUNTAIN VIEW, Calif., Jan. 05, 2022 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies, today announced that Fred Schwarzer, Chief Executive Officer, will present virtually at the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022 at 10:30 a.m. EST.

A live webcast of the event will be available on the “Events and Presentations” page in the “Investors” section of the Company’s website at https://investor.igmbio.com/news-and-events/events-and-presentations. A replay of the webcast will be archived on the Company’s website for 30 days following the presentation.

About IGM Biosciences, Inc.
Headquartered in Mountain View, California, IGM Biosciences is a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies. Since 2010, IGM Biosciences has worked to overcome the manufacturing and protein engineering hurdles that have limited the therapeutic use of IgM antibodies. Through its efforts, IGM Biosciences has created a proprietary IgM technology platform for the development of IgM antibodies for those clinical indications where their inherent properties may provide advantages as compared to IgG antibodies.

Contact
Argot Partners
David Pitts
212-600-1902
igmbio@argotpartners.com


FAQ

What is the date and time of IGM Biosciences' presentation at the J.P. Morgan Healthcare Conference?

IGM Biosciences' presentation will be on January 12, 2022, at 10:30 a.m. EST.

How can I watch the IGM Biosciences presentation live?

The IGM Biosciences presentation can be viewed live on the 'Events and Presentations' page in the Investors section of their website.

How long will the IGM Biosciences presentation be available for replay?

The replay of the IGM Biosciences presentation will be available for 30 days after the event.

What is the focus of IGM Biosciences?

IGM Biosciences focuses on creating and developing engineered IgM antibodies for therapeutic uses.

Where is IGM Biosciences headquartered?

IGM Biosciences is headquartered in Mountain View, California.

IGM Biosciences, Inc.

NASDAQ:IGMS

IGMS Rankings

IGMS Latest News

IGMS Stock Data

416.25M
21.74M
35.05%
63.99%
4.78%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
MOUNTAIN VIEW